Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alternative Splicing | 6 | 2023 | 220 | 1.740 |
Why?
|
| Genes, BRCA2 | 7 | 2016 | 162 | 1.190 |
Why?
|
| BRCA2 Protein | 7 | 2016 | 175 | 1.010 |
Why?
|
| Genes, BRCA1 | 10 | 2016 | 192 | 0.930 |
Why?
|
| Breast Neoplasms | 21 | 2016 | 3155 | 0.860 |
Why?
|
| BRCA1 Protein | 10 | 2016 | 216 | 0.830 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2016 | 2474 | 0.630 |
Why?
|
| RNA, Messenger | 9 | 2023 | 2089 | 0.580 |
Why?
|
| Mutation | 12 | 2023 | 4374 | 0.570 |
Why?
|
| Exons | 4 | 2012 | 454 | 0.530 |
Why?
|
| RNA Splicing | 2 | 2023 | 159 | 0.430 |
Why?
|
| Introns | 4 | 2012 | 304 | 0.390 |
Why?
|
| Neoplasms | 3 | 2023 | 3242 | 0.370 |
Why?
|
| Genetic Testing | 7 | 2016 | 565 | 0.360 |
Why?
|
| Germ-Line Mutation | 4 | 2016 | 382 | 0.360 |
Why?
|
| Breast Neoplasms, Male | 4 | 2010 | 31 | 0.360 |
Why?
|
| Alleles | 4 | 2007 | 1157 | 0.350 |
Why?
|
| Ovarian Neoplasms | 5 | 2016 | 800 | 0.280 |
Why?
|
| Nigeria | 7 | 2013 | 162 | 0.240 |
Why?
|
| Tubulin | 3 | 1997 | 61 | 0.240 |
Why?
|
| Microtubules | 3 | 1997 | 134 | 0.230 |
Why?
|
| Drosophila melanogaster | 4 | 1997 | 634 | 0.210 |
Why?
|
| Female | 28 | 2016 | 49868 | 0.180 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2001 | 11 | 0.170 |
Why?
|
| RNA Splice Sites | 2 | 2016 | 58 | 0.170 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 52 | 0.170 |
Why?
|
| Mutation, Missense | 1 | 2002 | 302 | 0.160 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2000 | 29 | 0.160 |
Why?
|
| Humans | 32 | 2023 | 95798 | 0.160 |
Why?
|
| Oncogenes | 1 | 2000 | 99 | 0.160 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2001 | 301 | 0.150 |
Why?
|
| Prevalence | 3 | 2014 | 1349 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 2 | 2010 | 155 | 0.140 |
Why?
|
| Molecular Sequence Data | 8 | 2012 | 3040 | 0.130 |
Why?
|
| Carcinoma | 1 | 2000 | 444 | 0.130 |
Why?
|
| Base Sequence | 6 | 2012 | 2342 | 0.120 |
Why?
|
| Pedigree | 5 | 2016 | 977 | 0.120 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 120 | 0.120 |
Why?
|
| Cohort Studies | 6 | 2016 | 3106 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2007 | 185 | 0.120 |
Why?
|
| Sperm Tail | 1 | 1995 | 2 | 0.110 |
Why?
|
| DNA Mutational Analysis | 4 | 2012 | 547 | 0.110 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2014 | 37 | 0.110 |
Why?
|
| Flagella | 1 | 1995 | 28 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 897 | 0.110 |
Why?
|
| Breast | 2 | 2014 | 297 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2014 | 161 | 0.100 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2013 | 28 | 0.100 |
Why?
|
| Middle Aged | 16 | 2016 | 28206 | 0.100 |
Why?
|
| Receptors, Estrogen | 3 | 2014 | 417 | 0.100 |
Why?
|
| Neoplasm Proteins | 3 | 2000 | 547 | 0.100 |
Why?
|
| Hereditary Breast and Ovarian Cancer Syndrome | 1 | 2012 | 12 | 0.090 |
Why?
|
| Parity | 2 | 2013 | 97 | 0.090 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 190 | 0.090 |
Why?
|
| Cell Line | 1 | 2016 | 2536 | 0.090 |
Why?
|
| Mutation Rate | 1 | 2012 | 55 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 2777 | 0.090 |
Why?
|
| Adult | 15 | 2016 | 28578 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 2012 | 272 | 0.080 |
Why?
|
| Male | 12 | 2012 | 45685 | 0.080 |
Why?
|
| Age Factors | 3 | 2016 | 1957 | 0.080 |
Why?
|
| Cell Nucleolus | 1 | 2010 | 25 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2010 | 46 | 0.080 |
Why?
|
| Risk Factors | 5 | 2013 | 5961 | 0.080 |
Why?
|
| Mitosis | 1 | 2010 | 152 | 0.080 |
Why?
|
| Gene Rearrangement | 1 | 2010 | 179 | 0.080 |
Why?
|
| Cell Division | 1 | 2010 | 701 | 0.070 |
Why?
|
| Kruppel-Like Factor 6 | 1 | 2008 | 5 | 0.070 |
Why?
|
| Systems Integration | 1 | 2008 | 34 | 0.070 |
Why?
|
| Database Management Systems | 1 | 2008 | 44 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2000 | 1730 | 0.070 |
Why?
|
| Genes | 1 | 1988 | 307 | 0.070 |
Why?
|
| Amino Acid Sequence | 5 | 2006 | 2090 | 0.070 |
Why?
|
| Fanconi Anemia Complementation Group F Protein | 1 | 2007 | 6 | 0.070 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 127 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2008 | 113 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 1988 | 648 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 109 | 0.070 |
Why?
|
| Genetics, Population | 2 | 2008 | 437 | 0.070 |
Why?
|
| Survival Rate | 1 | 2012 | 1971 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 412 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2014 | 149 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2010 | 301 | 0.060 |
Why?
|
| Age of Onset | 2 | 2014 | 344 | 0.060 |
Why?
|
| Breast Feeding | 1 | 2008 | 108 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2010 | 2495 | 0.060 |
Why?
|
| Prognosis | 2 | 2012 | 3990 | 0.060 |
Why?
|
| Glucuronosyltransferase | 1 | 2007 | 186 | 0.060 |
Why?
|
| Global Health | 1 | 2007 | 213 | 0.060 |
Why?
|
| Aneuploidy | 1 | 2005 | 61 | 0.060 |
Why?
|
| DNA Methylation | 2 | 2007 | 703 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2005 | 109 | 0.060 |
Why?
|
| Computational Biology | 1 | 2008 | 586 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 684 | 0.050 |
Why?
|
| Mammography | 2 | 2014 | 475 | 0.050 |
Why?
|
| Mephenytoin | 1 | 2003 | 2 | 0.050 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2003 | 17 | 0.050 |
Why?
|
| Risk | 2 | 2007 | 665 | 0.050 |
Why?
|
| Genetic Counseling | 2 | 2003 | 102 | 0.050 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2003 | 44 | 0.050 |
Why?
|
| Receptors, Virus | 1 | 2003 | 77 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 465 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 1766 | 0.050 |
Why?
|
| Aged | 7 | 2014 | 20848 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2000 | 703 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2008 | 1422 | 0.040 |
Why?
|
| Family Health | 1 | 2001 | 159 | 0.040 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2000 | 10 | 0.040 |
Why?
|
| Genes, erbB-2 | 1 | 2000 | 25 | 0.040 |
Why?
|
| Case Management | 1 | 2000 | 29 | 0.040 |
Why?
|
| Estrogen Antagonists | 1 | 2000 | 48 | 0.040 |
Why?
|
| Haplotypes | 3 | 2008 | 650 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2001 | 303 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 2006 | 435 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2000 | 85 | 0.040 |
Why?
|
| Ovariectomy | 1 | 2000 | 91 | 0.040 |
Why?
|
| Anticarcinogenic Agents | 1 | 2000 | 71 | 0.040 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2000 | 101 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2000 | 171 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2000 | 358 | 0.040 |
Why?
|
| Liver | 1 | 2003 | 1231 | 0.040 |
Why?
|
| Premenopause | 2 | 2013 | 63 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 2007 | 996 | 0.030 |
Why?
|
| Mastectomy | 1 | 2000 | 270 | 0.030 |
Why?
|
| Spermatogenesis | 2 | 1997 | 41 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 930 | 0.030 |
Why?
|
| Spermatids | 1 | 1997 | 5 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2013 | 1957 | 0.030 |
Why?
|
| Logistic Models | 2 | 2013 | 1267 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2010 | 796 | 0.030 |
Why?
|
| Founder Effect | 2 | 2008 | 106 | 0.030 |
Why?
|
| Genotype | 2 | 2012 | 1880 | 0.030 |
Why?
|
| DNA | 1 | 2001 | 1327 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 1995 | 99 | 0.030 |
Why?
|
| District of Columbia | 1 | 2014 | 19 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1995 | 297 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1995 | 215 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 209 | 0.030 |
Why?
|
| Geography | 1 | 2014 | 240 | 0.030 |
Why?
|
| SEER Program | 1 | 2014 | 235 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2014 | 196 | 0.030 |
Why?
|
| Phenotype | 1 | 2000 | 2575 | 0.030 |
Why?
|
| Pregnancy | 2 | 2013 | 3237 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2014 | 296 | 0.020 |
Why?
|
| Barbados | 1 | 2012 | 7 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 259 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2013 | 163 | 0.020 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 829 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 713 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 910 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 540 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 301 | 0.020 |
Why?
|
| Chromosome Breakpoints | 1 | 2010 | 15 | 0.020 |
Why?
|
| Animals | 4 | 1997 | 28888 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2010 | 44 | 0.020 |
Why?
|
| RNA, Fungal | 1 | 2010 | 43 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2010 | 128 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1714 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 815 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2010 | 212 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 326 | 0.020 |
Why?
|
| Registries | 1 | 2014 | 985 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2010 | 260 | 0.020 |
Why?
|
| Transformation, Genetic | 1 | 1988 | 41 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 1 | 1988 | 71 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 1988 | 52 | 0.020 |
Why?
|
| Oogenesis | 1 | 1988 | 47 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1988 | 152 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1988 | 257 | 0.020 |
Why?
|
| Online Systems | 1 | 2008 | 22 | 0.020 |
Why?
|
| Carcinoma, Medullary | 1 | 2008 | 9 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2008 | 11 | 0.020 |
Why?
|
| International Agencies | 1 | 2008 | 34 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2008 | 67 | 0.020 |
Why?
|
| Plasmids | 1 | 1988 | 291 | 0.020 |
Why?
|
| Ribosomal Proteins | 1 | 2008 | 45 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2008 | 151 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 701 | 0.020 |
Why?
|
| Models, Biological | 1 | 1995 | 1809 | 0.020 |
Why?
|
| United States | 2 | 2014 | 7764 | 0.020 |
Why?
|
| Africa | 1 | 2007 | 107 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2010 | 1156 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2008 | 85 | 0.020 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2008 | 126 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2008 | 196 | 0.020 |
Why?
|
| CpG Islands | 1 | 2007 | 169 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2008 | 166 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2000 | 10273 | 0.010 |
Why?
|
| Hydroxamic Acids | 1 | 2005 | 52 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 422 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2005 | 212 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2008 | 7215 | 0.010 |
Why?
|
| Azacitidine | 1 | 2005 | 149 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 364 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 4664 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 750 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2005 | 245 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1535 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2008 | 1010 | 0.010 |
Why?
|
| Cytochrome P-450 CYP2B6 | 1 | 2003 | 6 | 0.010 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2003 | 12 | 0.010 |
Why?
|
| Biotransformation | 1 | 2003 | 49 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 2003 | 49 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2005 | 465 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 1167 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 1931 | 0.010 |
Why?
|
| Adolescent | 2 | 2008 | 9873 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2010 | 2480 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 1560 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2003 | 620 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 594 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1756 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 1319 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2003 | 340 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 1192 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 7026 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 891 | 0.010 |
Why?
|
| Women's Health | 1 | 2000 | 109 | 0.010 |
Why?
|
| Infant | 1 | 2003 | 3360 | 0.010 |
Why?
|
| Moths | 1 | 1997 | 32 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 1997 | 186 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2003 | 3970 | 0.010 |
Why?
|
| Child | 1 | 2003 | 7618 | 0.010 |
Why?
|